Advanced Biomed is trading 7.38% up at $6.69 in pre-market on October 1, 2026, versus the September 30 close of $6.23; the catalyst remains uncertain. - No overnight announcement directly explaining the move surfaced in available coverage. - The latest company-specific item was a September 29 report that Advanced Biomed filed Form 12b-25 to delay its annual 10-K; coverage does not link it to the gain. - Broader indices showed mixed, modest moves.